Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Cash & Equivalents (2016 - 2025)

Harrow (HROW) has 13 years of Cash & Equivalents data on record, last reported at $72.9 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 54.35% year-over-year to $72.9 million; the TTM value through Dec 2025 reached $72.9 million, up 54.35%, while the annual FY2025 figure was $72.9 million, 54.35% up from the prior year.
  • Cash & Equivalents reached $72.9 million in Q4 2025 per HROW's latest filing, down from $74.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $96.3 million in Q4 2022 and bottomed at $6.5 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $55.8 million, with a median of $61.7 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: surged 1675.99% in 2021, then crashed 54.11% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $42.2 million in 2021, then soared by 128.31% to $96.3 million in 2022, then dropped by 23.04% to $74.1 million in 2023, then crashed by 36.23% to $47.2 million in 2024, then surged by 54.35% to $72.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $72.9 million in Q4 2025, $74.3 million in Q3 2025, and $53.0 million in Q2 2025.